β-Lactamase-Based Conductimetric Biosensor Assay for Protein-Protein Interactions
JoVE Encyclopedia of Experiments
Biological Techniques
0 views • 4:43 min • July 8th, 2025
To begin the β-lactamase-based conductimetric biosensor assay, take a transducer chip with working, counter, and reference electrodes. The working electrode has a conductive polymer coating, facilitating target antigen immobilization. The reference and counter electrodes lack this polymer coating.
Add a solution containing the target antigen onto the chip. Incubate. The antigen gets immobilized on the working electrode surface via non-covalent interactions. Wash to remove unbound antigens.
Add a blocking solution. Proteins in the solution attach to unbound sites on the working electrode and block them.
Add a bifunctional chimeric protein to the chip to detect the immobilized antigen. The chimeric protein comprises a β-lactamase enzyme — a bacterial protein responsible for antibiotic resistance. The enzyme is fused to a nanobody — the N-terminal variable region of single-domain antibodies.
Upon incubation, the nanobody of the protein binds to the immobilized target antigen. Wash to remove unbound chimeric proteins.
Plug the chip into a computer-controlled digital multimeter. Add a detection solution containing the antibiotic benzylpenicillin — a substrate for β-lactamase.
Benzylpenicillin binds to the β-lactamase of the antigen-bound chimeric protein and gets hydrolyzed — causing the release of protons. The protons induce a change in the electrical conductance of the polymer.
Plot the real-time difference in conductance between the reference electrode and the working electrode with the immobilized target antigen, confirming its interaction with the chimeric protein.
To begin the β-lactamase-based conductimetric biosensor assay, take a transducer chip with working, counter, and reference electrodes. The working electrode has a conductive polymer coating, facilitating target antigen immobilization. The reference and counter electrodes lack this polymer coating.
Add a solution containing the target antigen onto the chip. Incubate. The antigen gets immobilized on the working electrode surface via non-covalent interactions. Wash to remove unbound antigens.
Add a blocking solution. Proteins in the solution attach to unbound sites on the working electrode and block them.
Add a bifunctional chimeric protein to the chip to detect the immobilized antigen. The chimeric protein comprises a β-lactamase enzyme — a bacterial protein responsible for antibiotic resistance. The enzyme is fused to a nanobody — the N-terminal variable region of single-domain antibodies.
Upon incubation, the nanobody of the protein binds to the immobilized target antigen. Wash to remove unbound chimeric proteins.
Plug the chip into a computer-controlled digital multimeter. Add a detection solution containing the antibiotic benzylpenicillin — a substrate for β-lactamase.
Benzylpenicillin binds to the β-lactamase of the antigen-bound chimeric protein and gets hydrolyzed — causing the release of protons. The protons induce a change in the electrical conductance of the polymer.
Plot the real-time difference in conductance between the reference electrode and the working electrode with the immobilized target antigen, confirming its interaction with the chimeric protein.
Overview
This article describes a β-lactamase-based conductimetric biosensor assay for detecting target antigens. The method utilizes a transducer chip with electrodes to measure changes in electrical conductance upon antigen interaction.
Key Study Components
Area of Science
- Biosensing technology
- Electrochemistry
- Immunoassays
Background
- β-lactamase is an enzyme associated with antibiotic resistance.
- Conductimetric biosensors measure changes in electrical conductance.
- Chimeric proteins can enhance detection sensitivity.
- Non-covalent interactions are crucial for antigen immobilization.
Purpose of Study
- To develop a sensitive assay for detecting specific antigens.
- To utilize β-lactamase for signal amplification in biosensing.
- To demonstrate the feasibility of real-time conductance measurements.
Methods Used
- Preparation of a transducer chip with specific electrode coatings.
- Immobilization of target antigens on the working electrode.
- Application of a bifunctional chimeric protein for detection.
- Measurement of electrical conductance changes using a digital multimeter.
Main Results
- Successful immobilization of antigens on the working electrode.
- Detection of antigen-antibody interactions via conductance changes.
- Real-time monitoring of biosensor performance.
- Confirmation of the assay's sensitivity and specificity.
Conclusions
- The β-lactamase-based biosensor is effective for antigen detection.
- This method provides a rapid and sensitive approach for biosensing.
- Further optimization could enhance assay performance.
Frequently Asked Questions
Executive Industry Relevance
This conductimetric biosensor assay enables real-time, label-free detection of protein-protein interactions through measurable changes in electrical conductance. It supports early-stage target validation by providing quantitative, reproducible readouts that reduce mechanistic ambiguity in antibody-antigen binding studies. The assay’s compatibility with transducer chips and digital readout systems positions it as a scalable tool for discovery biology workflows requiring functional confirmation of biomolecular interactions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables direct interrogation of therapeutic hypotheses by confirming antigen-antibody binding through functional enzyme activity.
- Operational Value: Provides a homogeneous, wash-and-read format compatible with multiwell transducer arrays for medium-throughput screening.
- Predictive Confidence: Generates quantitative conductance signals that correlate with binding affinity, supporting go/no-go decisions in lead identification.
Screening & Assay Development
- Assay Readiness: Produces standardized, real-time electrical outputs that facilitate assay normalization and inter-laboratory reproducibility.
- Scalability: The transducer chip design allows for parallelization across multiple working electrodes, enabling panel-based antigen profiling.
- Reagent Compatibility: Utilizes stable chimeric proteins and antibiotic substrates that are amenable to large-scale production and storage.
Translational & Preclinical Research
- Translational Continuity: Supports biomarker-aligned validation by detecting antigen engagement in disease-relevant formats.
- Mechanistic De-risking: Confirms functional binding independent of fluorescence or radioactive labels, reducing assay interference risks.
- Preclinical Alignment: Generates quantitative interaction data that can inform dosing and target occupancy models in vivo.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from target validation through lead optimization, where functional confirmation of binding precedes downstream efficacy and safety profiling.
- Discovery Biology: Supports hypothesis-driven screening by validating that selected antibodies engage targets via specific, measurable interactions.
- Screening: Delivers real-time kinetic-like conductance traces that enable discrimination between specific and nonspecific binding events.
- Analytics: Outputs differential conductance measurements that allow quantitative comparison across antibody variants or antigen concentrations.
- Translational Research: Provides binding confirmation data that can be correlated with cellular or tissue-based target engagement assays.
- Enterprise Reuse: The transducer platform can be regenerated and reused across multiple target panels, supporting cost-effective target validation campaigns.
Operational & Enterprise Impact
- Scientific Value: Reduces false positives by requiring functional enzyme activity as a binding-dependent readout.
- Operational Value: Eliminates need for fluorescent labels or radioactive isotopes, simplifying assay workflow and reducing safety overhead.
- Strategic Value: Accelerates target validation timelines by providing immediate, instrument-based feedback on binding events.
- Portfolio Impact: Enables objective comparison of antibody candidates based on quantitative binding strength, supporting risk-adjusted resource allocation.
Implementation Considerations
- Requires expertise in protein engineering to generate functional bifunctional chimeric proteins.
- Dependent on access to computer-controlled potentiostats or multimeters capable of microSiemens-resolution conductance measurements.
- Necessitates optimization of blocking buffers to minimize nonspecific protein adsorption on conductive polymer surfaces.
- Must account for substrate diffusion kinetics when interpreting real-time conductance changes in complex sample matrices.
- Performance may vary with antigen orientation and density on the working electrode, requiring empirical titration for each target.
Biopharma FAQs
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Related Videos
0 Views
Application of Biolayer Interferometry (BLI) for Studying Protein-Protein Interactions in Transcription
Related Videos
0 Views
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Related Videos
0 Views
Amplified Luminescent Proximity Homogeneous Assay: A Bead-Based Proximity Assay to Screen Small Molecules Inhibiting Protein-Protein Interactions
Related Videos
0 Views
Graphene Biosensor-Based Field-Effect Biosensing to Detect Protein-Protein Interactions
Related Videos
0 Views
Proximity Ligation Assay to Study In Situ Protein-Protein Interactions
Related Videos
0 Views
Biotinylated Cell-Penetrating Peptide Probe to Detect Protein-Protein Interactions
Related Videos
0 Views
Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
Related Videos
0 Views
The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Related Videos
0 Views
Capturing the Interaction Kinetics of an Ion Channel Protein with Small Molecules by the Bio-layer Interferometry Assay
Related Videos
0 Views
Last updated: 29 August 2026